Integral Health Asset Management, LLC

Position in LNTH — Lantheus Holdings, Inc.

CIK 1773206 New York, NY

Back to LNTH Full portfolio

Position in LNTH

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$21,078,600

+$11,597,350 QoQ

Shares Held

190,000

+52.0% QoQ

Ownership

0.291%

of shares outstanding

% of Portfolio

0.86%

of 13F equity value

Holder Rank

#59

of 466 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in LNTH Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Integral Health Asset Management, LLC holds $58,952,600 across 4 Drug Manufacturers - Specialty & Generic names. LNTH ranks #2 (35.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	NBIX	Neurocrine Biosciences Inc	150,000	$25,281,000
2	LNTH	Lantheus Holdings, Inc. This page	190,000	$21,078,600
3	BIOA	BioAge Labs, Inc.	300,000	$7,353,000
4	ALKS	Alkermes plc.	100,000	$5,240,000

All Filings in LNTH

Export CSV

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$21,078,600	190,000	+52.0%	Shares	Sole	2026-08-14
2026-03-31	$9,481,250	125,000	+25.0%	Shares	Sole	2026-05-15
2025-12-31	$6,655,000	100,000	—	Shares	Sole	2026-02-17
No filing history on record for this holder in this stock.